Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.

[1]  J. Cuzick,et al.  Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16 , 2015, International journal of cancer.

[2]  Thomas M. Harris,et al.  Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma , 2015, Cancer medicine.

[3]  J. Greally,et al.  Genome-wide assays that identify and quantify modified cytosines in human disease studies , 2015, Epigenetics & Chromatin.

[4]  K. Yoshihara,et al.  Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma , 2014, International Journal of Clinical Oncology.

[5]  K. K. van de Vijver,et al.  Molecular biomarkers in cervical cancer diagnosis: a critical appraisal. , 2013, Expert opinion on medical diagnostics.

[6]  J. Cuzick,et al.  Human papillomavirus testing for triage of women with low‐grade squamous intraepithelial lesions , 2013, International journal of cancer.

[7]  A. Moscicki,et al.  Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. , 2012, Obstetrics and gynecology.

[8]  Aaron Golden,et al.  The Wasp System: an open source environment for managing and analyzing genomic data. , 2012, Genomics.

[9]  David C Wilbur,et al.  The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. , 2012, Journal of lower genital tract disease.

[10]  J. Kaur,et al.  p16INK4a and p15INK4b gene promoter methylation in cervical cancer patients , 2012 .

[11]  A. Kaufmann,et al.  p16INK4a and p14ARF mRNA expression in Pap smears is age-related , 2012, Modern Pathology.

[12]  Andreu Alibés,et al.  HumMeth27QCReport: an R package for quality control and primary analysis of Illumina Infinium methylation data , 2011, BMC Research Notes.

[13]  Maureen A Sartor,et al.  Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis , 2011, Epigenetics.

[14]  M. Einstein,et al.  Age-Stratified Performance of the Cervista HPV 16/18 Genotyping Test in Women with ASC-US Cytology , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[15]  S. Levanat,et al.  Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing® assays. , 2011, International journal of oncology.

[16]  K. Seow,et al.  P16 Methylation Is an Early Event in Cervical Carcinogenesis , 2011, International Journal of Gynecologic Cancer.

[17]  M. von Knebel Doeberitz,et al.  Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results. , 2010, Gynecologic oncology.

[18]  M. Allday,et al.  Epigenetic reprogramming of host genes in viral and microbial pathogenesis , 2010, Trends in microbiology.

[19]  J. Greally,et al.  Optimized design and data analysis of tag-based cytosine methylation assays , 2010, Genome Biology.

[20]  Y. Furtado,et al.  The Presence of Methylation of the p16INK4A Gene and Human Papillomavirus in High-grade Cervical Squamous Intraepithelial Lesions , 2010, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[21]  M. Sherman,et al.  Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. , 2009, Gynecologic oncology.

[22]  Cheng-Chang Chang,et al.  Identification of novel DNA methylation markers in cervical cancer , 2008, International journal of cancer.

[23]  Kathleen R. Cho,et al.  Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. , 2008, Cancer research.

[24]  A. Gazdar,et al.  Evaluation of candidate methylation markers to detect cervical neoplasia. , 2007, Gynecologic oncology.

[25]  O. Caballero,et al.  Aberrant Promoter Methylation Can be Useful as a Marker of Recurrent Disease in Patients with Cervical Intraepithelial Neoplasia Grade III , 2007, Tumori.

[26]  G. Peters,et al.  Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.

[27]  A. Hanselaar,et al.  p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia. , 2006, Gynecologic oncology.

[28]  Cara M Martin,et al.  Molecular profiling of cervical neoplasia , 2006, Expert review of molecular diagnostics.

[29]  M Arbyn,et al.  Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis , 2006, The Lancet.

[30]  S. Franceschi,et al.  Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis , 2005, The Lancet.

[31]  C. Wheeler,et al.  Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. , 2005, Journal of the National Cancer Institute.

[32]  David R. Scott,et al.  The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. , 2005, Journal of the National Cancer Institute.

[33]  István Simon,et al.  BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes , 2005, Nucleic acids research.

[34]  L. Elit.  Pitfalls in the Diagnosis of Cervical Intraepithelial Neoplasia 1 , 2004, Journal of lower genital tract disease.

[35]  M. Lindström,et al.  Predictive Significance of the Alterations of p16INK4A, p14ARF, p53, and Proliferating Cell Nuclear Antigen Expression in the Progression of Cervical Cancer , 2004, Clinical Cancer Research.

[36]  A. García-Carrancá,et al.  Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[37]  F. X. Bosch,et al.  Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. , 2003, Journal of the National Cancer Institute. Monographs.

[38]  M. Mansukhani,et al.  Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome , 2003, Molecular Cancer.

[39]  J. Herman,et al.  A systematic profile of DNA methylation in human cancer cell lines. , 2003, Cancer research.

[40]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[41]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[42]  M. Sherman,et al.  Comparisons of HPV DNA detection by MY09/11 PCR methods , 2002, Journal of medical virology.

[43]  S. Greenland,et al.  Estimating causal effects. , 2002, International journal of epidemiology.

[44]  H. S. Kim,et al.  Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  A. Gazdar,et al.  Aberrant methylation during cervical carcinogenesis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  L. Koutsky,et al.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. , 2000 .

[47]  J. Herman,et al.  In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Burk,et al.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems , 1997, Journal of clinical microbiology.

[49]  M. Braga,et al.  Exploratory Data Analysis , 2018, Encyclopedia of Social Network Analysis and Mining. 2nd Ed..

[50]  R. Burk,et al.  Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. , 1986, American journal of obstetrics and gynecology.

[51]  J. Kaur,et al.  p16(INK4a) and p15(INK4b) gene promoter methylation in cervical cancer patients. , 2012, Oncology letters.

[52]  J. Lee,et al.  Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. , 2010, Gynecologic oncology.

[53]  A. Contreras-Paredes,et al.  Nuclear co-expression of p14ARF and p16INK4A in uterine cervical cancer-derived cell lines containing HPV. , 2010, Cancer biomarkers : section A of Disease markers.

[54]  L. Koutsky.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. , 2000, Journal of the National Cancer Institute.